Patients diagnosed with epilepsy face a number of challenges. Their disease is complex, and even those treated at specialty clinics are not well informed about their condition [1] . Stigma is common and can have severe consequences [2] caused by patients' perceived "otherness" [3] . Interventions tend to focus on educating the general population to alter their attitudes and beliefs [4] . Another approach is empowering people with chronic illness by harnessing the Internet to create a community of similar people to share experiences and support one another.
The Internet has a number of useful features for social support [5] and enables "ridiculously easy group formation" [6] . Although the use of online communities in epilepsy is not new [7] , recent developments include increasing uptake of high-speed Internet access, the ready availability of "Web 2.0" applications [8] , mobile access, and the e-patient movement (e.g., www.e-patients.net [9] ). In 2008 it was estimated that around 60% of patients with epilepsy in the United States had access to the Internet [10] .
Epilepsy-specific sites such as PatientsLikeMe.com, Epilepsy.com, and SeizureTracker.com may provide patients with a number of benefits that have been recognized as important in permitting patients to live well with their epilepsy [11] . First, they may improve knowledge of their disease via high-quality content. Second, the social support can improve patients' self-management through a number of mechanisms such as improved self-efficacy, positive social norms, and reduction of stigma [12] . Third, helping patients track their disease through online seizure diaries avoids backfilling [13] and creates the potential to record additional, valid details to share with health care professionals. Mobile applications even allow a third party (e.g., a parent) to video-record the seizure for later review.
In studies, individual online educational interventions such as WebEase have produced benefits in epilepsy self management, medication adherence, sleep quality, self-efficacy, and social support [14] , and this system will be made widely available later in 2011 [15] . Bergin et al. [16] proposed that an open, multicenter online system with data entered by clinicians (recently realized as EpiNet [17] ) would help clinical management, comparative effectiveness research, and trial recruitment.
Outside epilepsy, online communities have been found to improve the quality of patient-physician interactions [18] and improve patients' emotional well-being, perceived disease control, empowerment, medical literacy [19] , and ability to cope [20] . Patients with stigmatizing illnesses are particularly likely to have higher Internet use for social support, finding health information and communicating with a physician online [21, 22] . Although such benefits may not accrue to those who still do not have Internet access, through a "collateral health" effect, even patients who have not directly participated in an online service may still benefit [23] .
PatientsLikeMe.com is a patient-centered online platform [24] . Briefly, the site allows patients with life-changing illnesses to share their medical data with other patients "like them" by longitudinally charting patient-reported outcomes, symptoms, side effects, medical history, and treatments. Because data are collected in a structured format (e.g., symptoms are coded in MedDRA, treatments are supported by the Multum database, with patient-entered data curated by health care professionals), they can be aggregated to form interactive reports that reflect real-life trends [25] , and patient reported outcomes may even serve to identify treatment effects [26] .
Launched in January 2010, new platform features specific to epilepsy were developed with funding provided by UCB. We developed a "seizure meter" (Figs. 1 and 2 ) that allows patients to record the type, frequency, and severity of their seizures on a weekly basis. In addition, there are a number of epilepsy-specific questions asked of users who complete their condition history, including driving status, family history, pregnancy, and diagnostic tests. Epilepsy-specific treatments such as antiepileptic drugs, surgical options, and dietary interventions were pre-programmed into the system, and adverse events detected from patients taking the sponsor's (UCB's) medications are submitted to the manufacturer's drug safety department for safety reporting.
Finally, we developed an epilepsy-specific research platform to conduct a longitudinal research project with widely used patientreported outcome (PRO) measures consisting of the Quality of Life Inventory in Epilepsy (QOLIE-31/P) [27] , Hospital Anxiety and Depression Scale (HADS) [28] , and EQ-5D [29] . These data are in the process of being collected longitudinally, with interim analyses presented as the study progresses [30] . Participants in the PRO project are shown where they stand in relation to other members of the community using physical, mental, and social summary scores derived from the QOLIE-31/P (Fig. 3) , with the intention of improving their awareness of factors influencing their QOL, such as depressive symptoms, social support, and stigma [31] . All of these data are shared openly with all other members of the community, allowing users to search for one another on any of the medical variables captured (e.g., epilepsy type, seizure type, treatments).
A previous study identified a number of perceived benefits (e.g., better communication with health care professionals, learning about symptoms, improved understanding of treatments and side effects) arising from use of PatientsLikeMe among patients with amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson's disease, human immunodeficiency virus (HIV), fibromyalgia, and mood disorders [24] . The purpose of this study was to gather feedback on perceived benefits from use of our online service by people with epilepsy.
In addition to the generic perceived benefits identified in other conditions we also anticipated epilepsy-specific benefits. On the basis of the stigma involved in epilepsy we hypothesized that, prior to using the site, many patients with epilepsy would be relatively isolated and have few social face-to-face relationships with other patients with epilepsy, but that an online community had the potential to improve this situation. Further, we hypothesized that those who participated most with other "patients like them" in the site and formed strong ties with others would perceive greater benefits than those who did not.
Methods
An online survey was used to field a set of epilepsy-specific questions relating to site usage, as well as generic questions replicating earlier work [24] . Questions related to diagnostic confidence and confidence in sharing health data and how that might have changed through use of the site; quality of care (reported separately [32] ); treatment history; medication adherence; decision support around treatments or symptoms; social support; epilepsy self-management; and demographics. Our questionnaire is presented in supplementary material (see Appendix). At the time of data collection the community was accessible only to members in the United States; since April 2011 it is now open internationally. On September 15, 2010, invitations were sent to 2362 patients with epilepsy who had been members for at least 30 days, regardless of their level of log-in activity. The invitation was sent as a private message within the PatientsLikeMe community. Sampled patients had their own passwordprotected log-in. They could complete the survey only once; we have tools to prevent multiple accounts originating from the same location. The survey was not mandatory to complete to continue using the site. No incentives were offered; the total number of questions varied slightly by participants' own responses to filter questions.
A reminder message was sent within a week to those who had not yet completed the survey. The survey remained open for a period of 14 days. Only data from completed questionnaires are presented here. As specified in the terms of use, members of PatientsLikeMe join the site with the expectation that they will be participating in research. As a service evaluation project with no anticipated adverse consequences for participation, institutional review board approval was not sought for this project. The recruitment message was sent from P.W., who can easily be contacted by potential participants, and can be viewed in supplementary material (see Appendix). We generated a "benefit score," which was constructed from 20 of the 25 potential perceived benefits listed in Tables 1 and 2 (range: 0-20). We excluded perceived benefits (indicated by footnote a) likely to be tautological (i.e., positively scoring "Locating another person who helped you understand what it is like to take a specific medication for your condition" would bias toward an association with site participation) or those that might not be universally regarded as a benefit (e.g., changing physician). A single point was given if patients endorsed any of the following categories: "Very helpful," "Moderately helpful," "Strongly agree," and "Agree." No points were assigned for other responses including "Does not apply."
Data analysis was performed by P.W. using Statistics Package for the Social Sciences (SPSS Version 18.0). Association between categorical variables was assessed using the χ 2 test; normally distributed demographic data were compared using Student's t test (two groups) or between-group ANOVA (three or more groups). Where overall between-group differences on ANOVA were significant, post hoc t tests with Bonferroni correction were applied to test for paired comparisons. Nonparametric between-group differences were tested using the Kruskal-Wallis test. Correlations were performed using Pearson's r. Tests performed were two-tailed with α set at P b 0.05.
Results
Invitations to participate were sent to 2362 patients with epilepsy. According to Web logs, at the time of analysis 348 members (15% of those invited) logged in and opened the private message invitation. Of these, 282 patients (81% of users logging in during this period, 12% of total) started the survey, and of these, 221 (64% of users logging in, 9% of total) completed all questions. Sixty-one patients (18% of users logging in, 3% of total) gave only partial responses and were excluded from this analysis. Twenty-one patients (6% of users logging in, 1% of total) opted out of the survey. To test for response bias we compared the demographic characteristics of responders against those of nonresponders. Responders were a little older than nonresponders (mean age: 40 years (SD 12) for responders vs 36 years (SD 12) for nonresponders, F(3,1871) = 8.259, P b 0.001) and, accordingly, had experienced seizures longer (mean duration since first seizure: 23 years (SD 15) for responders vs 19 years (SD 14) for nonresponders, F(3,1806) = 5.757, P b 0.001). Unsurprisingly, responders had logged in to the site more times since joining than nonresponders (median log-ins: 15 (range 2-802) for responders vs 3 (range 0-548) for nonresponders, U = 58648.5, P b 0.001). Most nonresponders (66%) had not logged into the site since the survey invitation was sent. Responders were no different from nonresponders with respect to sex or epilepsy type (P > 0.05).
Mean participant age was 40 years (SD: 12); two-thirds were female, 84% Caucasian. The largest proportions of respondents (44%) had at least some college education and were married (40%); most were not working for pay (53%). About half of the respondents had a partial epilepsy syndrome, with one-third reporting a generalized syndrome and 16% unknown. The most frequently reported syndrome was temporal lobe epilepsy (32%), followed by unspecified syndrome (15%), grand mal seizures on awakening (10%), other partial syndromes (8%), and juvenile myoclonic epilepsy (6%). About half the respondents had been seizure free in the preceding 7 days, but about one in five had had more than five seizures in the same period. Mean disease duration was 23 years (SD: 15) since first seizure and 19 years (SD: 14) since diagnosis. The largest proportion of respondents were on polytherapy (≥2 AEDs, 60%); commonly used AEDs included levetiracetam (both immediate release and extended release, n = 86, 39%), lamotrogine (n = 60, 27%), topiramate (n = 37, 17%), and carbamazepine (n = 36, 16%). Most respondents reported that they were treated regularly by a neurologist (70%), and only 20% by an epileptologist. Table 1 lists items that were asked both of people with epilepsy who used the website and, separately as part of a previous study, of other PatientsLikeMe communities including those with MS (N = 347), Parkinson's disease (N = 287), ALS (N = 218), fibromyalgia (N = 150), HIV (N = 177), and mood disorders (N = 144) [24] . The most highly endorsed benefits were for features of the site that support self-management, such as learning about symptoms (51% "very" or "moderately" helpful), understanding possible side effects of medication (47%), and recording symptoms (45%).
Comparison of the two studies yielded similar results. For instance, 25% of patients with epilepsy rated the site as "very" or "moderately" helpful in decisions to change medication, relative to 27% of patients from the other communities. Where significant differences were found, these seemed to be accounted for by the fact that patients with epilepsy were more likely not to have tried a particular site feature relative to other communities [24] . This may be due to the relatively recent launch of the community or some characteristics of epilepsy compared with other diseases. For example, stopping a medication completely would be less likely than in some other conditions. In support of the former hypothesis, the proportion of "does not apply" responses was negatively correlated with number of days on the site (r= −0.162, P = 0.016) and number of logins (r = −0.186, P =0.005). Table 2 summarizes responses to epilepsy-specific questions regarding the utility of the site; highly rated benefits included learning about seizures (55% "very" or "moderately" helpful), finding another person with the same symptoms (59% agreed), and recording seizures to help manage the condition (45% helpful). Some benefits occurred less frequently but would presumably have a greater impact on a patient's self-management. Thirty percent agreed they received better care from health care professionals from recording symptoms on PatientsLikeMe, 27% agreed that their medication compliance improved because of the site, 27% reported reduced side effects, 18% agreed they had fewer emergency room visits, and 17% reported that, because of the site, they had insisted on seeing an epilepsy specialist.
Participants were asked how closely they had followed directions on when and how to take their drugs in the past 30 days. Most patients (70%, N = 154) reported being adherent all of the time; 27% (N = 60) reported "most of the time," with only 2% (N = 5) reporting "about half of the time"; 0.5% (N = 1) reported "some of the time"; and 0.5% (N = 1) were "never adherent." Improved adherence as a result of using the site was reported by 27% (N = 60) of users, of whom 75% (N = 45) reported they had been adherent "all of the time" in the past 30 days. In an open text response one patient wrote "In the past I had never really followed the advice or been instructed on how this can affect you. But after seeing some readers post the importance of taking your meds regularly (same time of day consistently) it has really helped me stay on top of things."
Another benefit reported by patients was help in reducing treatment side effects (endorsed by 27%, N = 58). Another patient wrote: "In looking for similar side effects with other patients I noticed a trend on PatientsLikeMe. By collecting this data and discussing it with my neurologist we were able to come up with a more satisfactory combination of meds over the next 6 months."
Participants were asked how many people with epilepsy they knew in both "the real world" and on PatientsLikeMe with whom they would feel comfortable discussing information or opinions about epilepsy. Prior to joining PatientsLikeMe, 30% (N = 67) of respondents knew nobody with epilepsy with whom they could talk; 63% (N = 42) of these users now had at least one person on PatientsLikeMe with whom they could talk about epilepsy.
Across all respondents, a mean of seven benefits from use of the site were perceived (SD: 6.2, median: 6, range: 0-20). Table 3 and Fig. 4 show the distribution of the number of perceived benefits by number of close relationships with other patients in the system. Post hoc Bonferroni tests revealed that patients with no close relationships to other patients on the system perceived significantly fewer benefits (mean difference [95% CI]) from using the site than patients who had three or four friends (− 4 [−8 to −0.6], P = 0.08), 5 to 9 friends (−5 [−10 to −0.8], P = 0.006), or ≥10 friends (− 6 [−9 to −2], P b 0.001). a Excluded from the benefit count. N/A = Does not apply/Never tried to use for this. 
Discussion
Patients with epilepsy reported an array of perceived benefits from using PatientsLikeMe. Users gained a better understanding of their seizures (58%), learned more about a symptom or treatment (55%), felt greater control over their condition (50%), had reduced side effects (27%), improved adherence (27%), and had insisted on seeing a specialist (17%) or, in some cases, even changed their physician (10%). Perhaps as a result of these perceived benefits, 45% of users agreed that using the site had improved their quality of life. Relative to other disease populations on PatientsLikeMe [24] , the epilepsy community had not yet used all of the features available to them, though this might be expected to change over time.
The most prominent benefits to be reported by users with epilepsy included features that were intentionally designed into the site, such as disease tracking (seizures and symptoms) and practical advice on disease management (minimizing side effects). Although there are no custom features on PatientsLikeMe to encourage medication adherence or changes in health care provider, the social community allowed users to identify problems and share solutions, presumably via social tools and viewing each other's profiles. It is feasible that adding additional functionality to support these goals could increase the proportion of patients experiencing benefits.
The Internet provides opportunity for patients to find and connect with other patients like them. About a third of our respondents (30%) did not know anyone with epilepsy with whom they could talk about their condition; of these, 63% found at least one person with epilepsy with whom they could connect on PatientsLikeMe. The number of benefits perceived was associated with the number of relationships that patients had with other patients in the system. Options for communication on the site include open discussion in the forum, private message exchange, or leaving comments on each other's profiles [33] . Many of the benefits identified relied on learning from the experience of others; presumably the more opportunities to learn from others, the easier this would be to achieve. Future research could identify tools to better connect patients within a peer group of optimal size and composition.
The concept of online tools for tracking epilepsy is not new, as evidenced by systems including Epilepsy.com, SeizureTracker.com, EpiTrax, and a number of academic research projects. However, although these systems allow patients with epilepsy to share their information with their doctors, they do not permit sharing with other patients, nor aggregation of structured data. For example, in a traditional message board it might be possible for users to start a thread about medication dosage or to write their medication regime as a "signature" at the end of each message. On PatientsLikeMe, treatment data on antiepileptic drugs are collected in a structured format and dosages are displayed as a histogram; for instance, the treatment report on levetiracetam shows dosages entered by 750 patients with epilepsy (http://www.patientslikeme.com/treatments/show/3700-levetiracetam). These structured, aggregated data reflect a larger sample collected in a more systematic way than patients using the Internet could access previously and might enhance their understanding of how typical their dosage might be.
Clearly, giving patients more access to data is not entirely without risk. Public interactions between patients are moderated by professional staff to ensure that users adhere to a code of conduct. For example, "Ideal PatientsLikeMe Members share personal experiences without trying to provide medical advice." Fortunately the vast majority of users understand that changes to medication need to be discussed with their physician. To date, we have not identified any reports of medical harm arising from interactions between patients; this is an area that requires renewed attention in the literature [34] . However there is also the question of how prepared health care professionals may be for the change in information balance brought by the Internet [35, 36] , and we did identify a single case where a patient-provider relationship broke down, in part, because a patient increased his or her health literacy. The female patient wrote in the forum that her physician "complains … that I had (all of a) sudden showed up for (appointments) knowing the proper medical terms for things-that I 'was using terms like pre-ictal' and the like.… [The physician] could no longer deal with me because, get this: I 'had gotten with a bunch of people on the Internet' and that they were now 'advising' my treatment/care!"
We agree with Bergin that "not … all epilepsy research should be conducted in the manner we have outlined here … a double-blind randomized controlled trial is the optimal way of comparing two or more alternative treatments" [16] . However, there may be an opportunity to develop hybrid models where clinicians provide diagnostic validation and objective measures and patients use seizure-tracking tools, patient reported outcomes, adherence monitoring tools, and social networks in parallel. This has the potential to make more efficient use of physician time by highlighting issues in need of attention, improving patient adherence to medical advice, and giving patients psychosocial support. Some patients may be self-experimenting with diet, exercise, or even pharmaceutical treatments, and a standardized data collection tool has the potential to help identify any potential benefits at the individual or even group level [26] .
Many of the limitations to this study are shared by all online studies, including but not limited to: participation rates, biases, accuracy of data collection, and variations in care systems. An important limitation is that we lack independent verification that site members are really patients with epilepsy. Future research directions could include collaborations with specialty clinics to recruit verified patients. The benefits identified are perceived benefits reported only by those patients who chose to participate in the survey, though the fact that these users represent 64% of all users who logged in during this period suggests these results are at least representative of regular site users. Future work should use objectively collected data such as hospital admissions and medication refills. The overall response rate (9%) was lower than in other communities [24] , with response rates ranging from 14 to 29% (mean: 19%). This can be explained by a low number of log-ins for most of the invited sample. Of the invited patients who logged in to the site during the response window, 64% completed the survey. We also left the survey open for completion for a period of 14 days, which may have been too short for some patients to participate; however, typically we receive 80% of responses to Fig. 4 . Means plot showing the relationship between mean total number of perceived benefits (circle, whiskers represent 95% confidence intervals) and number of friends on PatientsLikeMe. Post hoc comparisons between groups (using Bonferronicorrected t tests) were significant (P b 0.001) for differences between "none" and all other categories. surveys in the first 2 days after launch and have not found lengthening the recruitment window to substantially improve completion rates. An alternative approach to future work might be for a "service evaluation" survey to be triggered by a given number of site log-ins; this might ensure a more representative sample of respondents than a cross-sectional approach.
Previous research has shown that the PatientsLikeMe epilepsy population is more likely to be female, to have more patients in their twenties to forties, and to have more patients on polytherapy than patients with epilepsy in a health insurance claims database [37] . Our sample is broadly similar to that of the online study of patients with epilepsy of Escoffery et al., whose sample was 57% female and 88% Caucasian, but was a little younger (mean age 38 years) and more likely to have had at least some college education [10] . Escoffery et al. identified a number of demographic differences between online samples and their clinic samples; a larger proportion of whites were online, with a lower level of disability and higher levels of education [10] . A clear limitation to the Internet more broadly is the "information divide" that inevitably arises between those who are computerliterate and those who are not [38] . This may be particularly true of veteran populations, where only half of patients are reported to have access to the Internet [39] . It is likely that our users represent early adopters of health technology, but it is hoped that barriers to access will be reduced in the future. There may be additional unmeasured biases in the nature of patients who return to the website or completed our survey. Although PatientsLikeMe is a for-profit company and funded in part by industry, we attempt to be transparent with our members (a link on the front page of the website leads readers to a section on "How We Make Money"), and we use the platform to conduct research for industry, not as an advertising platform.
Patients with epilepsy evaluated a data-sharing website as having benefits in supporting their self-management; such technology may be more easily scaled than traditional real-world support groups and may be of value to providers and nonprofits in improving the outcomes of their patients. Future research should be conducted using traditional interventional methodologies, for example, a randomized trial of a "prescription" for patients to use PatientsLikeMe versus other types of websites such as static epilepsy information (e.g., WebMD) or a community that allows qualitative discussion but not data sharing (e.g., Braintalk), with objectively captured outcome data.
Conclusion
An online community that is structured like PatientsLikeMe encourages patients to share and learn from data that are potentially more systematic than in previous efforts. Sharing of health data through the use of seizure-tracking tools, medication records, and other opportunities for patient self-report that are dynamically linked and referenced in online discussion may have the potential to improve disease management and health outcomes of people with epilepsy through improved disease knowledge and self-management. Further work is needed to yield important clinical benefits such as improved seizure control, reduced emergency room visits, and improved medication adherence through online tools for people with epilepsy.
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